Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.

about

HIV-Associated Neurocognitive Disorders: A Global Perspective.HIV p24 antigen is quantifiable at low concentrations in human cerebrospinal fluid with digital ELISA and is associated with decreased neuropsychological performance.

P2860

Q46077781-ED8D1B1F-AF99-4214-98CB-C1BB2D4C1451 Q47641205-C4EBD50C-9AF4-42DC-8B36-31E74BC48EA5

P2860

Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.

Item

http://www.wikidata.org/entity/Q39040592

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Determining optimal impairment ...... disorder screening procedure.

@en

Determining optimal impairment ...... disorder screening procedure.

@nl

type

Item

label

Determining optimal impairment ...... disorder screening procedure.

@en

Determining optimal impairment ...... disorder screening procedure.

@nl

prefLabel

Determining optimal impairment ...... disorder screening procedure.

@en

Determining optimal impairment ...... disorder screening procedure.

@nl

P1476

Determining optimal impairment ...... disorder screening procedure.

@en

P2093

Angela Carberry

http://www.w3.org/2001/XMLSchema#string

Jody Kamminga

http://www.w3.org/2001/XMLSchema#string

Mark Bloch

http://www.w3.org/2001/XMLSchema#string

Trina Vincent

http://www.w3.org/2001/XMLSchema#string

P2860

“Mini-mental state”

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

Identification of an abbreviated test battery for detection of HIV-associated neurocognitive impairment in an early-managed HIV-infected cohort

Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline.

The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories.

A systematic review of the screening accuracy of the HIV Dementia Scale and International HIV Dementia Scale.

HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research

Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging.

Concurrent validity of a computer-based cognitive screening tool for use in adults with HIV disease.

A neuropsychological investigation of multitasking in HIV infection: implications for everyday functioning.

P304

753-767

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13803395.2016.1263282

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Lucette Cysique

Bruce J Brew

P577

2017-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28052738

http://www.w3.org/2001/XMLSchema#string

Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.

about

P2860

P2860

Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698